Related Experiment Video
Updated: Jun 19, 2026

Experimental Analysis of Apoptotic Thymocyte Engulfment by Macrophages
Published on: May 24, 2019
Effect of high mobility group box-1 protein on apoptosis of peritoneal macrophages
Xiao-Mei Zhu1, Yong-Ming Yao, Hua-Ping Liang
1Department of Microbiology and Immunology, Burns Institute, First Hospital Affiliated to the Chinese PLA General Hospital, Beijing 100048, People's Republic of China.
Abstract:
The present study was performed to clarify the effects of high mobility group box-1 protein (HMGB1), a recently described late-acting pro-inflammatory cytokine, on apoptosis of macrophages. Treatment with HMGB1 (0.01, 0.1, 1, 10 microg/ml for 24 h, or 10 microg/ml for 6, 12, 24, 48 h) resulted in a dose- and time-dependent induction of apoptosis in mice macrophages, peaked at 24 h after 10 microg/ml HMGB1 stimulation. HMGB1 treatment enhanced the receptor for advanced glycation end products (RAGE) expression and caspase-3 activation in macrophages. Blockage of RAGE and caspase-3 activation could significantly reduce apoptosis of macrophages induced by HMGB1. The activity of NF-kappaB/p65 in macrophages was decreased after HMGB1 treatment. These results suggested that HMGB1-induced apoptosis of macrophages in a dose- and time-dependent manner. RAGE, together with caspase-3 activation and inhibition of NF-kappaB signaling pathways, might be involved in the pathogenesis of macrophage apoptosis induced by HMGB1.
Insights
High mobility group box-1 protein (HMGB1) triggers macrophage apoptosis in a dose- and time-dependent manner. This process involves receptor for advanced glycation end products (RAGE) and caspase-3 activation, with decreased NF-kappaB/p65 activity.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- High mobility group box-1 protein (HMGB1) is a pro-inflammatory cytokine.
- Macrophage apoptosis plays a role in various inflammatory diseases.
Purpose of the Study:
- To investigate the effects of HMGB1 on macrophage apoptosis.
- To elucidate the molecular mechanisms underlying HMGB1-induced macrophage apoptosis.
Main Methods:
- Macrophage cultures were treated with varying concentrations and durations of HMGB1.
- Receptor for advanced glycation end products (RAGE) expression, caspase-3 activation, and NF-kappaB/p65 activity were assessed.
- Inhibitors of RAGE and caspase-3 were used to evaluate their role in apoptosis.
Main Results:
- HMGB1 induced apoptosis in macrophages in a dose- and time-dependent manner, peaking at 24 hours.
- HMGB1 treatment increased RAGE expression and caspase-3 activation.
- Blocking RAGE and caspase-3 significantly reduced HMGB1-induced apoptosis.
- NF-kappaB/p65 activity was decreased following HMGB1 treatment.
Conclusions:
- HMGB1 induces macrophage apoptosis through RAGE and caspase-3 activation.
- Inhibition of NF-kappaB signaling pathways may contribute to HMGB1-induced macrophage apoptosis.
- These findings provide insights into the role of HMGB1 in inflammatory processes involving macrophages.
More Related Videos
08:21Isolation of Murine Peritoneal Macrophages to Carry Out Gene Expression Analysis Upon Toll-like Receptors Stimulation
Published on: April 29, 2015
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway